Zhi-qiu Hu
Minhang, 201199, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 29, 2023
Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 10, 2020
Downregulation of PDGF-D Inhibits Proliferation and Invasion in Breast Cancer MDA-MB-231 Cells.
Journal: Clinical breast cancer
Published: September 30, 2020
LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 29, 2020
MicroRNAs and long non-coding RNAs in liver surgery: Diagnostic and therapeutic merits.
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: October 28, 2019
Cross-talk among AFAP1-AS1, ACVR1 and microRNA-384 regulates the stemness of pancreatic cancer cells and tumorigenicity in nude mice.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 18, 2018
Self-management and self-efficacy status in liver recipients.
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: June 12, 2015
Clinical operational tolerance in liver transplantation: state-of-the-art perspective and future prospects.
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: February 09, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026